Amgen has terminated its co-development and commercialization of brodalumab with AstraZeneca after observing suicidal ideation and behavior in clinical trial participants.
Light or moderate alcohol intake has been associated with health benefits such as reduced risk of cardiovascular events, but these benefits disappear as intake increases.
The FDA today approved a new 200 unit/mL formulation of Lilly’s Humalog KwikPen for patients with type 1 and type 2 diabetes.
Noting national drug shortages often disproportionately affect pediatric patients, the Pediatric Pharmacy Advocacy Group (PPAG) is encouraging the FDA to include child-specific considerations in its policies for preventing and mitigating drug shortages.
Hospitals serving large populations of non-native English speakers perform worse on patient satisfaction scores that are tied to reimbursement from the US Centers for Medicare and Medicaid Services.
The FDA today approved a new treatment for chronic obstructive pulmonary disease: tiotropium bromide and olodaterol inhalation spray.
The FDA had accepted for review Tris Pharma’s New Drug Application for its extended-release liquid amphetamine to treat ADHD in children.
Electronic prescribing technology is permitting pharmacists to focus less on administrative tasks and more on providing direct patient care.
Although previous reports focused on the risks of antidepressant use in new mothers, a recent study stressed the benefits these drugs provide for women with postpartum depression.